QUALIS PHARMA SOLUTIONS LIMITED
Executive Summary
Qualis Pharma Solutions Limited shows a stable financial position with growing net assets and no overdue filings, reflecting low immediate solvency or regulatory risks. However, the absence of employees and unaudited micro-entity accounts warrant further inquiry into operational sustainability and financial reliability. Overall, it presents a low-risk profile for investors with standard due diligence recommended.
View Full Analysis Report →- Legal registered address
- Suite 9 30 Bancroft Hitchin Hertfordshire United Kingdom SG5 1LE Copied!
Latest financial results as of 4 August 2025- Current assets
- £22.98k
- Current creditors
- £4.09k
- Shareholders funds
- £19.16k
View full financial accounts- Current assets
- £22.98k
- Current creditors
- £4.09k
- Shareholders funds
- £19.16k
- Company number
- 13666794 Copied!
Accounts
Latest annual accounts were to 31 October 2024
Next annual accounts are due by 31 July 2026
Company financial year end is on 31 October 2025
Confirmation statement
Latest confirmation statement statement dated 6 October 2024
Next statement due by 20 October 2025
Nature of business (SIC)
70229 - Management consultancy activities other than financial management
74909 - Other professional, scientific and technical activities not elsewhere classified
Latest company documents
| Date | Description |
|---|---|
| 01/05/251 May 2025 | Micro company accounts made up to 2024-10-31 |
| 31/10/2431 October 2024 | Annual accounts for year ending 31 Oct 2024 |
| 14/10/2414 October 2024 | Confirmation statement made on 2024-10-06 with updates |
| 20/03/2420 March 2024 | Micro company accounts made up to 2023-10-31 |
| 31/10/2331 October 2023 | Annual accounts for year ending 31 Oct 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company